Cumberland Pharmaceuticals (CPIX) Long-Term Debt Repayments (2017 - 2025)
Historic Long-Term Debt Repayments for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Q1 2025 value amounting to $10.0 million.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments rose 3033.04% to $10.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 5642.15%. This contributed to the annual value of $36.0 million for FY2024, which is 317.0% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at $10.0 million for Q1 2025, which was up 3033.04% from $6.3 million recorded in Q4 2024.
- Cumberland Pharmaceuticals' 5-year Long-Term Debt Repayments high stood at $20.0 million for Q2 2022, and its period low was $6.3 million during Q4 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' median Long-Term Debt Repayments value was $10.9 million (recorded in 2023), while the average stood at $11.3 million.
- Per our database at Business Quant, Cumberland Pharmaceuticals' Long-Term Debt Repayments skyrocketed by 7647.06% in 2021 and then crashed by 4581.52% in 2023.
- Cumberland Pharmaceuticals' Long-Term Debt Repayments (Quarter) stood at $14.0 million in 2021, then crashed by 45.0% to $7.7 million in 2022, then increased by 1.8% to $7.8 million in 2023, then dropped by 19.44% to $6.3 million in 2024, then surged by 58.9% to $10.0 million in 2025.
- Its Long-Term Debt Repayments was $10.0 million in Q1 2025, compared to $6.3 million in Q4 2024 and $11.0 million in Q3 2024.